Wave Life Sciences ( ($WVE) ) has provided an update. On November 17, 2025, Wave Life Sciences updated its corporate presentation, emphasizing ...

Somatic mutations with effects similar to those seen with VEXAS syndrome are increasingly seen as possible drivers of ...

GATC brought together a broad coalition of researchers and executives in cell and gene therapy, gene editing, drug discovery and AI as well as patients and advocates.

The sorghum salt tolerant gene SbTEF1 was identified by genome-wide association study (GWAS) and the PAV284 which located in ...

Hairs, ligatures and possibly other evidence collected after three 8-year-old boys were murdered on May 5, 1993 in West ...

Extreme longevity is linked to compressed cognitive decline and increased resilience to AD and vascular pathology.

Lead candidate from mutant selective JAK2V617F JH2 inhibitor program advancing with IND filing expected in the first quarter of 2026Lead ...

Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced the launch of oncoReveal® Lymphoid, a ...

Investing.com -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) stock surged 10% following the announcement of strategic agreements with Fidelion Diagnostics to commercialize VitaGuard, a liquid biopsy ...

Using full genome sequencing data from more than 347,000 individuals, researchers quantified how much genetic differences explain human traits such as height, body mass index, fertility, and disease ...

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel: Oxford, UK Wednesday, November 12, 2025, 17:00 Hrs [IST] Oxford Gene Technology (OGT), a Sysmex ...

A study has confirmed the effectiveness of a drug that can treat acquired genetic hearing loss. On the 11th, a research team led by Professor Ji Heon-young, Professor Jang Seung-hyun of Yonsei ...